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When faced with nutrient deprivation, Saccharomyces
cerevisiae cells enter into a nondividing resting state,
known as stationary phase. The Ras/PKA (cAMP-
dependent protein kinase) signaling pathway plays an
important role in regulating the entry into this resting
state and the subsequent survival of stationary phase
cells. The survival of these resting cells is also depend-
ent upon autophagy, a membrane trafficking pathway
that is induced upon nutrient deprivation. Autophagy is
responsible for targeting bulk protein and other cyto-
plasmic constituents to the vacuolar compartment for
their ultimate degradation. The data presented here
demonstrate that the Ras/PKA signaling pathway inhib-
its an early step in autophagy because mutants with
elevated levels of Ras/PKA activity fail to accumulate
transport intermediates normally associated with this
process. Quantitative assays indicate that these in-
creased levels of Ras/PKA signaling activity result in an
essentially complete block to autophagy. Interestingly,
Ras/PKA activity also inhibited a related process, the
cytoplasm to vacuole targeting (Cvt) pathway that is
responsible for the delivery of a subset of vacuolar pro-
teins in growing cells. These data therefore indicate that
the Ras/PKA signaling pathway is not regulating a
switch between the autophagy and Cvt modes of trans-
port. Instead, it is more likely that this signaling path-
way is controlling an activity that is required during the
early stages of both of these membrane trafficking path-
ways. Finally, the data suggest that at least a portion of
the Ras/PKA effects on stationary phase survival are the
result of the regulation of autophagy activity by this
signaling pathway.
Saccharomyces cerevisiae cells respond to nutrient depriva-
tion by arresting cell division and entering into a nondividing
resting state, known as the stationary phase (1, 2). Cells in this
resting state exhibit a diminished rate of metabolic activity, an
increased resistance to a variety of environmental stress con-
ditions and an altered pattern of gene expression (1–3). Entry
into this quiescent state is essential for the long term survival
of these cells as mutants that do not assume stationary phase
characteristics rapidly lose viability upon nutrient limitation
(1, 2). Moreover, this budding yeast, like most other eu-
karyotes, spends the majority of its existence in this resting
state awaiting the signals needed to trigger new rounds of cell
division. This latter observation has suggested that the tran-
sitions between the mitotic cycle and these periods of quies-
cence might be key points of proliferative control (4, 5). How-
ever, despite the importance of these resting states, relatively
little is known about the mechanisms controlling the entry
into, and subsequent maintenance within, this stationary
phase of growth.
Recent studies have identified a number of genes that are
important for the long term survival of S. cerevisiae stationary
phase cells (2, 6–9). Interestingly, many of these genes encode
proteins important for the process of macroautophagy (10, 11).
Macroautophagy (to be referred to as simply autophagy for the
remainder of this report) is a degradative pathway that is
responsible for delivering bulk protein and other constituents
of the cytoplasm to the vacuole for degradation (11–13). This
pathway is induced by nutrient deprivation and mutants that
are defective for autophagy rapidly lose viability during sta-
tionary phase growth (10, 14). Autophagy begins with the en-
capsulation of cytoplasmic material through the formation of a
double membrane structure, termed the autophagosome (12,
13, 15, 16). Recent work has indicated that this intermediate
originates from a novel cytoplasmic site, termed the pre-auto-
phagosomal structure (12, 17, 18). The outer membrane of the
autophagosome subsequently fuses with the vacuole releasing
the internal vesicle, the autophagic body, into the lumen of this
degradative compartment (12, 19). The hydrolytic enzymes
within the vacuole then degrade both the delimiting membrane
and the contents of the autophagic body (19–22). When this
pathway is fully induced, it is generally responsible for the
majority of the protein and membrane turnover occurring in
those cells (21, 23).
Previous work has implicated the Tor signal transduction
pathway in the control of both autophagy and stationary phase
entry in S. cerevisiae. The inactivation of this signaling path-
way results in the induction of autophagy and in a growth
arrest that resembles that associated with stationary phase
cells (24, 25). The Tor proteins are conserved serine/threonine-
specific protein kinases that appear to coordinate the overall
growth rate with nutrient availability in eukaryotic cells (26,
27). Consistent with this proposition, a wide variety of Tor
pathway targets important for the control of cell growth have
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been identified in both yeast and other eukaryotic cells
(26–29).
Stationary phase metabolism in S. cerevisiae is also con-
trolled by a second signaling pathway that involves the Ras
proteins and the cAMP-dependent protein kinase, PKA1 (1, 2,
30). The eukaryotic Ras proteins are small, GTP-binding pro-
teins that function as molecular switches by oscillating be-
tween an active GTP-bound form and an inactive GDP-bound
form (31, 32). S. cerevisiae has two Ras proteins, Ras1p and
Ras2p, that directly interact with the enzyme adenylyl cyclase
(33, 34). This interaction results in higher intracellular levels
of cAMP and ultimately in increased PKA activity (35, 36). A
role for this pathway in the regulation of stationary phase was
suggested by the phenotypes of mutants with altered levels of
Ras/PKA activity. For example, mutants with constitutively
elevated levels of Ras/PKA activity fail to adopt stationary
phase characteristics upon nutrient limitation (36). Con-
versely, mutations that inactivate this pathway result in a
permanent stationary phase-like arrest (30, 37, 38). Thus, two
different signaling pathways involving the Ras and Tor pro-
teins appear to play a significant role in the control of station-
ary phase biology in S. cerevisiae (2, 26).
We are interested in characterizing the role of the Ras/PKA
signaling pathway in the regulation of autophagy. Although
the nature of this regulation has not been examined in detail,
a recent study has found that increased levels of Ras/PKA
signaling activity result in a decrease in the autophagic activity
induced by the drug, rapamycin (39). Rapamycin is a potent
inhibitor of Tor activity in vivo and is often used to study the
consequences of Tor pathway inactivation (40, 41). Thus, these
data were consistent with the Ras/PKA pathway having some
regulatory role in the autophagy process. In this study, we
examined this regulation in detail and found that Ras/PKA
signaling activity controls a relatively early step in the auto-
phagy pathway. This Ras-sensitive step likely precedes the
formation of the autophagosome as these transport intermedi-
ates were not formed in cells with elevated levels of Ras/PKA
signaling activity. This signaling pathway also inhibited a vac-
uolar trafficking pathway that is related to autophagy but
functions during the log phase of growth. This cytoplasm to
vacuole targeting (Cvt) pathway shares many mechanistic fea-
tures with autophagy and most of the proteins required for
autophagy are also required for Cvt transport (42–45). In all,
these data indicate that Ras/PKA activity is not regulating the
switch between autophagy and the Cvt pathway in vivo and is
instead controlling an activity that is required during the early
stages of both of these membrane trafficking pathways.
EXPERIMENTAL PROCEDURES
Growth Media—Standard Escherichia coli growth conditions and
media were used throughout this study (46). The yeast rich growth
medium, YPAD, consists of 1% yeast extract, 2% Bacto-peptone, 50 mg/l
adenine-HCl, and 2% glucose. The yeast YM minimal growth medium
consists of 0.67% yeast nitrogen base lacking amino acids, 2% glucose
and all of the growth supplements required for cell proliferation (8). The
nitrogen starvation medium, SD-N, consists of 0.17% yeast nitrogen
base lacking amino acids and ammonium sulfate and 2% glucose.
Growth media reagents were from DIFCO.
Plasmid Constructions—The construction of the MET3-RAS2val19
integrating plasmid, pPHY446, was described previously (7). The inte-
gration of this allele was directed to the RAS2 locus by digesting this
plasmid with XmnI prior to transformation of yeast cells. For the high
copy number TPK1 plasmid, pPHY2056, a 1.7-kb PCR fragment con-
taining the TPK1 gene was cloned into the pRS426 plasmid (47, 48). A
dominant negative allele of RAS2, known as RAS2ala22, was generated
by a site-directed mutagenesis of a RAS2 plasmid, pJW82, that was
kindly provided by Dr. Jasper Rine. The pJW82 plasmid has RAS2
placed under the control of the inducible promoter from the GAL1 gene.
The site-directed mutagenesis was performed with the Transformer
mutagenesis kit (Clontech) and resulted in the substitution of an ala-
nine residue for the glycine normally found at position 22 of Ras2p. The
resulting plasmid was called pPHY2128. The effects of this dominant
negative allele have been described previously (49, 50).
For the Ape1p overexpression experiments, the APE1 coding se-
quences were placed under the control of the inducible promoter from
the yeast CUP1 gene; CUP1 encodes a copper-binding metallothionein
(51, 52). Expression from the CUP1 promoter was induced by the
addition of 100 M CuSO4 to the growth medium.
Yeast Strain Construction and Growth Conditions—The strains used
in this study are listed in Table I. Unless otherwise noted, strains were
from our laboratory collections or were derived during the course of this
work. Standard yeast genetic methods were used for the construction of
all strains (53).
Strains carrying the MET3-RAS2val19 allele were grown in medium
containing 500 M methionine to keep the MET3 promoter in its re-
pressed state. RAS2val19 expression was induced by transferring these
cells to medium that lacks methionine (7, 54). For the experiments with
the dominant negative allele, GAL1-RAS2ala22, a wild-type strain,
TN125, was transformed with either pPHY2128 or a control vector,
pRS416. These strains were grown to mid-log phase in YM-glucose
minimal medium and were transferred to YM medium containing 5%
galactose and 2% raffinose. Culture samples were collected at the
indicated time intervals and alkaline phosphatase assays were per-
formed to assess autophagy activity, as described below.
Alkaline Phosphatase-based Autophagy Assays—Autophagy levels
were measured with an alkaline phosphatase-based assay that has
been described previously (55). In general, autophagy was induced by
transferring cells to a medium that lacks a nitrogen source, SD-N.
Alkaline phosphatase levels were typically determined for cells that
had been incubated in SD-N medium for 0 and 15 h at 30 °C. The
increase in alkaline phosphatase activity that was observed following
the period of starvation was a direct measure of the autophagy activity
present in those cells. For the assays, the cells were resuspended in 200
l of the assay buffer (250 mM Tris-SO4, pH 9.4, 10 mM MgSO4, 10 M
ZnSO4) and disrupted by vortexing with glass beads. The cell lysates
were clarified by centrifugation at 10,000 g for 5 min, and 50 l of the
resulting protein extract was added to a tube containing 500 l of assay
buffer and 50 l of a 1 mg/ml solution of p-nitrophenylphosphate. This
reaction mix was incubated for 30 min at 35 °C, and the reaction was
then stopped by the addition of 500 l of 2 M glycine-NaOH, pH 11. The
absorbance at 405 nm of the resulting solution was then measured. One
unit of activity is defined as the release of 1 mol of p-nitrophenyl/
min/mg of protein. The protein concentrations in the cell extracts were
determined with a bicinchoninic acid protein assay kit (Sigma). For the
rapamycin experiments, autophagy assays were performed on cells that
had been treated with 0.2 g/ml rapamycin for 0, 1, or 3 h at 30 °C.
1 The abbreviations used are: PKA, cAMP-dependent protein kinase;
CPY, carboxypeptidase Y; Cvt, cytoplasm to vacuole targeting; EM,
electron microscopy.
TABLE I
Yeast strains used in this study
Strain Genotype Alias Ref.
PHY3513 TN125, RAS2::HIS3-RAS2val19
PHY3992 TVY1, RAS2::HIS3-RAS2val19
PHY3993 TDY2, RAS2::HIS3-RAS2val19
TDY2 MAT his3-200 leu2–3,112 lys2–80 trp1-901 ura3–52 suc2-9 vam3::LEU2 p(vam3ts) PHY3671 74
TN125 MATa ade2 his3 leu2 lys2 trp1 ura3 pho8::pho860 PHY2801 24
TVY1 MAT his3-200 leu2–3,112 lys2–80 trp1-901 ura3–52 suc2-9 pep4::LEU2 PHY3670 86
YYK126 MATa ade2 his3 leu2 lys2 trp1 ura3 pho8::pho860 atg1::LEU2 PHY2802 24
YYK130 MATa ade2 his3 leu2 lys2 trp1 ura3 pho8::pho860 atg13::LEU2 PHY2803 24
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Western Immunoblotting and Immunoprecipitations—For the West-
ern immunoblots, protein extracts were prepared by a glass-beading
method described previously (56, 57). The resulting protein extracts
were separated on SDS-polyacrylamide gels and transferred to nitro-
cellulose membranes (Hybond ECL, Amersham Biosciences) at 4 °C.
The membranes were then probed with either anti-Ape1p (58), anti-
Pgk1p, or anti-Atg13p antisera, and the immunoreactive proteins were
detected with anti-rabbit IgG (Amersham Biosciences) used at a dilu-
tion of 1:3000. The Supersignal chemiluminescent substrate (Pierce)
was subsequently used to illuminate the reactive bands. The car-
boxypeptidase Y (CPY) immunoprecipitation experiments were per-
formed as described (57, 59).
Electron Microscopy—The pep4 (TVY1) and vam3ts (TDY2) strains
carrying either a control vector or an integrated version of the MET3-
RAS2val19 construct, were grown overnight in YM-glucose medium con-
taining 500 M methionine. The cells were washed twice with water and
transferred to a YM-glucose medium lacking methionine for 4 h to
induce RAS2val19 expression. The cells were then washed twice with
water and transferred to SD-N for 3 h. All incubations for the pep4
strains were performed at 30 °C. For the vam3ts strains, the incubations
in YM-glucose media were performed at 26 °C, whereas the incubations
in the SD-N medium were done at 37 °C to inactivate the temperature-
sensitive Vam3p present. Cells were fixed with permanganate, dehy-
drated with acetone, and embedded with Spurr’s resin as described (60).
70-nm sections were mounted on nickel grids, and stained with uranyl
acetate and lead citrate to be finally imaged with a Philips CM-100
transmission electron microscope.
RESULTS
Elevated Levels of Ras/PKA Signaling Activity Inhibited Au-
tophagy—We were interested in examining the role of the
Ras/PKA pathway in the regulation of autophagy. For our
initial experiments, autophagy activity was measured with an
assay that analyzes the vacuolar delivery of a cytoplasmic
variant of the Pho8p alkaline phosphatase following a shift to
conditions of nitrogen starvation (55). The wild-type Pho8p is
synthesized as an inactive zymogen that is delivered to the
vacuolar compartment via the traditional secretory pathway
(61, 62). Upon arrival in the vacuole lumen, this zymogen is
activated by a proteolytic cleavage that removes a C-terminal
propeptide (61). The cells used for the autophagy assay express
a Pho8p variant, Pho8p60, that lacks a transmembrane do-
main that functions as an internal signal sequence and nor-
mally directs this protein into the secretory pathway (55, 61).
As a result, Pho8p60 is found in the cytosol in its inactive,
precursor form. Following the induction of autophagy, this
protein is packaged into autophagosomes and delivered to the
vacuole where it can be activated (12, 55). Previous work has
indicated that the levels of alkaline phosphatase activity pres-
ent are proportional to the amount of autophagy occurring in
these cells (12, 55).
The Pho8p60 assay was used to examine the effect that
elevated levels of Ras/PKA signaling activity would have on the
autophagy process. To increase Ras/PKA activity, a dominant
hyperactive allele of RAS2, known as RAS2val19, was intro-
duced into the assay strain. The presence of this allele results
in constitutively elevated levels of Ras/PKA signaling activity
(30, 36). For most of the experiments in this study, we used an
inducible version of this allele where RAS2val19 was placed
under the control of the promoter from the yeast MET3 gene (7,
63, 64). This promoter is repressed when cells are grown in
medium containing methionine and induced when methionine
is absent (7, 54). For the autophagy assays, alkaline phospha-
tase activity was assessed after 0 and 15 h of nitrogen starva-
tion. The level of autophagy was indicated by the difference in
enzymatic activity found at these two time points (55).
We found that the presence of RAS2val19 resulted in an
essentially complete block in autophagy (Fig. 1A). The defect
observed in the RAS2val19 cells was comparable to that seen in
mutants lacking proteins essential for autophagy, like atg1
and atg13 (Fig. 1A) (65, 66). Since the yeast Ras proteins have
multiple effectors (2, 30, 67, 68), we tested whether this inhi-
bition of autophagy was due to the cAMP/PKA effector path-
way. For this analysis, a high copy plasmid containing the
TPK1 gene was introduced into the assay strain. TPK1 encodes
one of the three PKA catalytic subunits in S. cerevisiae and its
FIG. 1. Elevated levels of Ras/PKA signaling activity inhibited
autophagy. A, RAS2val19 mutants exhibited very low levels of autoph-
agy following nitrogen starvation. The indicated strains were grown to
mid-log phase at 30 °C and transferred to the nitrogen starvation me-
dium, SD-N, for 0 or 15 h. Autophagy levels were measured with the
alkaline phosphatase-based assay as described under “Experimental
Procedures.” The levels of autophagy induction are indicated by the
relative increase in alkaline phosphatase activity that is induced by the
nitrogen starvation. The strains used were wild type (TN125), atg1
(YYK126), atg13 (YYK130), and RAS2val19 (PHY3513). All strains
except PHY3513 carried the control vector, pRS413. B, increased levels
of PKA activity inhibited autophagy activity. Alkaline phosphatase
assays were performed as described above in A. The strains used were
wild-type (TN125 with the control vector, pRS426), HC-TPK1 (wild-
type carrying the high-copy number TPK1 plasmid, pPHY2056) and
atg1 (YYK126 with pRS426). C, elevated levels of Ras/PKA signaling
activity inhibited the rapamycin-mediated induction of autophagy. The
indicated strains were grown to mid-log phase in YM-glucose medium
and then treated with 0.2 g/ml rapamycin for 0, 1, or 3 h. Autophagy
levels were then assessed with the alkaline phosphatase-based assay
system. The strains analyzed were those used in A.
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overexpression results in high levels of PKA activity (35). We
found that the presence of this TPK1 plasmid also resulted in a
severe inhibition of autophagy (Fig. 1B). Thus, constitutively
elevated levels of Ras/PKA activity prevented the induction of
autophagy that normally occurs upon nitrogen starvation.
We also tested whether the presence of the RAS2val19 allele
would inhibit the autophagy induced by rapamycin, a drug that
inhibits Tor activity in vivo (28, 40). For these experiments,
cells were treated with rapamycin for either 0, 1, or 3 h and the
levels of autophagy activity were assessed with the alkaline
phosphatase-based assay system. In wild-type cells, treatment
with rapamycin resulted in a significant increase in autophagy
activity at both time points (Fig. 1C). In contrast, no increase in
autophagy activity was observed in the RAS2val19 mutant cells
(Fig. 1C). This block to autophagy was essentially as complete
as that observed in the atg1 and atg13 mutants. Thus, the
Ras/PKA signaling pathway inhibited the autophagy activity
induced by either nitrogen starvation or the rapamycin-medi-
ated inactivation of the Tor pathway.
Inactivation of the Ras/PKA Pathway Led to an Induction of
Autophagic Activity—The above data indicated that the Ras/
PKA signaling pathway negatively regulates autophagy. The
experiments in this section tested whether the inactivation of
this pathway would be sufficient to induce autophagy even
under growth conditions that normally inhibit this process. For
these experiments, we used a dominant negative allele of
RAS2, known as RAS2ala22 (49, 50, 69). This allele encodes an
altered Ras2p that binds tightly to Cdc25p, the guanine nucle-
otide release factor that promotes the formation of the active
Ras2p-GTP complex (49, 50). The overexpression of this altered
protein prevents Cdc25p from activating the normal Ras2p
(and Ras1p) and results in a loss of Ras/PKA signaling activity
and in a stationary phase-like growth arrest (49). We used a
construct where the RAS2ala22 coding sequences were placed
under the control of the promoter from the GAL1 gene. This
construct provides high levels of expression only in media that
contain galactose as the primary carbon source (70). The basic
experiment therefore involved measuring autophagy levels
during growth in galactose medium.
As expected, we found that cells containing the GAL1-
RAS2ala22 construct exhibited a growth defect in galactose me-
dium (Fig. 2A). For these experiments, cells were grown to
mid-log phase in YM-glucose medium and then transferred to a
YM medium that contained 5% galactose. Transfer to this
galactose medium resulted in a slower growth rate, and ulti-
mate growth arrest, of those cells containing the GAL1-
RAS2ala22 hybrid gene. An essentially complete arrest was
observed after 36 to 40 h of growth in the galactose medium
(Fig. 2A). Consistent with previous work (49), we found that the
majority of cells in the growth-arrested cultures were unbud-
ded and thus were likely in the G1/G0 phase of the cell cycle
(data not shown). Shortly after this arrest, an induction in
autophagy activity was observed specifically in those cells that
were expressing the dominant negative Ras2p (Fig. 2B). The
autophagy levels present were comparable to those observed in
wild-type cells after nitrogen starvation. In contrast, no signif-
icant increase in autophagy activity was observed at these
times in the wild-type control cells (Fig. 2B). Therefore, these
data are consistent with the proposition that the inactivation of
the Ras/PKA pathway is sufficient to induce autophagy activity
in S. cerevisiae.
Elevated Levels of Ras/PKA Signaling Activity Inhibited the
Formation of Both Autophagosomes and Autophagic Bodies—
The above work indicated that Ras/PKA signaling activity reg-
ulated autophagy but did not identify the step that might be
affected. We therefore turned to electron microscopy (EM) in an
attempt to gain more insight into the nature of this Ras-medi-
ated block to autophagy. The primary advantage of this EM
analysis is that it can provide qualitative information that can
supplement the quantitative data provided by the alkaline
phosphatase-based assays (71, 72). For these experiments, the
MET3-RAS2val19 allele was introduced into the pep4 and
vam3ts mutant strains. PEP4 encodes a vacuolar protease that
is required for the degradation of autophagic bodies (19, 73).
VAM3, on the other hand, encodes a t-SNARE protein that is
required for the fusion of the autophagosome with the vacuolar
membrane (74). Therefore, following the induction of autoph-
agy, pep4 mutants accumulate autophagic bodies within the
vacuole, and vam3 mutants accumulate autophagosomes in the
cytoplasm (74, 75) (Fig. 3).
The basic experimental approach was to test whether ele-
vated levels of Ras/PKA signaling activity would have any
effect on the accumulation of these autophagy pathway inter-
mediates. To induce RAS2val19 expression, the cells were grown
in YM medium lacking methionine for 4 h and then transferred
FIG. 2. Inactivation of the Ras/PKA signaling pathway was
sufficient to induce an autophagy response. A, expression of the
dominant negative RAS2ala22 allele resulted in a growth arrest after
transfer to the galactose medium. Wild-type cells (TN125) carrying
either a control vector, pRS416 (circles), or the GAL1-RAS2ala22 plas-
mid, pPHY2128 (triangles), were grown to mid-log phase in YM-glucose
medium and transferred to a YM medium that contained 5% galactose
and 2% raffinose. The culture density was assessed by spectrophoto-
metric measurement of the OD600 at the indicated times after the
transfer to galactose-containing growth medium. B, inactivation of the
Ras/PKA pathway resulted in an induction of autophagy activity. Au-
tophagy levels were assessed with the alkaline phosphatase-based as-
say as described under “Experimental Procedures.”
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to SD-N starvation medium for 3 h. The vam3ts allele encodes
a temperature-sensitive protein that is functional at 26 °C but
not at 37 °C (74). Therefore, for the vam3ts experiments, the
strains were grown at 26 °C in the YM media and incubated at
37 °C in the SD-N starvation medium. For the pep4 strains,
all incubations were performed at 30 °C. After starvation, the
pep4 and vam3ts cells were processed for the EM analysis as
described under “Experimental Procedures.” We found that the
presence of the RAS2val19 allele blocked the formation of both
the autophagic bodies in the pep4 mutant and the autopha-
gosomes in the vam3ts strain (Fig. 3). No obvious autophagy-
related structures were identifiable in either mutant strain
when the RAS2val19 allele was being expressed. In contrast,
both of these intermediate structures were readily observed in
the relevant control strains (Fig. 3). These studies therefore
indicate that the Ras/PKA pathway must be inhibiting an early
step in the autophagy pathway, a step that precedes (or is
required for) the formation of the autophagosome.
The Presence of the RAS2val19 Allele Inhibited the Cvt- and
Starvation-dependent Processing of the Vacuolar Aminopepti-
dase Ape1—The Cvt pathway is responsible for delivering a
subset of vacuolar proteins, including the aminopeptidase
Ape1p (21, 76). Cvt transport occurs constitutively in growing
cells and represents an alternative delivery route to the tradi-
tional secretory pathway (21, 58). Cvt transport and autophagy
appear to be mechanistically similar as most of the proteins
required for one process are also required for the other (44, 45).
In addition, the same type of double membrane vesicle is ob-
served during both processes, the autophagosome during auto-
phagy and the Cvt vesicle during Cvt transport (22, 77). There-
fore, we were interested in testing whether the Ras/PKA
pathway also regulated Cvt transport.
Ape1p is the best characterized cargo of the Cvt pathway
(22). It is synthesized as an inactive precursor (prApe1p) that is
activated by a proteolytic cleavage that occurs in the vacuole
(58). This processing of prApe1p serves as a marker for vacu-
olar delivery and is the standard assay used to measure Cvt
transport activity. Therefore, to assess the effect of Ras/PKA
activity on this pathway, we analyzed Ape1p processing in cells
that expressed the RAS2val19 allele. For these experiments, we
prepared protein extracts from log phase cultures of wild-type
and RAS2val19 cells and performed an immunoblot with an
antibody specific for Ape1p to monitor prApe1p processing.
Surprisingly, we found that Ape1p was not present in the
extracts from the RAS2val19 cells (Fig. 4A). A whole genome
expression analysis indicated that this absence of Ape1p was
likely due, at least in part, to a defect in RNA polymerase II
transcription.2 These microarray experiments indicated that
APE1 mRNA levels were down 3–4-fold in RAS2val19 cells
relative to an isogenic wild-type control strain. Interestingly,
the mRNA level of a gene encoding a second protein carried by
the Cvt pathway, AMS1, was also down 2-fold in the
RAS2val19 cells. AMS1 encodes the vacuolar hydrolase, -man-
nosidase I (78). Therefore, Ras/PKA signaling activity was ap-
parently inhibiting the expression of the only two known cargo
proteins for the Cvt pathway.
To analyze Cvt activity, the APE1 gene was placed under the
control of the promoter from the CUP1 gene (see “Experimental
Procedures”). CUP1 encodes a copper-binding metallothionein
and expression from the CUP1 promoter is induced by the
presence of copper in the growth medium (51, 52). Cells con-
taining this CUP1-APE1 construct exhibited Ape1p levels in
YM-glucose medium that were just slightly higher than those
normally provided by the wild-type APE1 promoter (data not
shown; see Fig. 4B). More importantly, the expression levels
from this promoter were not significantly influenced by Ras/
PKA signaling activity (Fig. 4B). Thus, this construct was used
to assess Cvt activity in wild-type and RAS2val19 strains by
analyzing Ape1p processing as described above.
We found that the presence of RAS2val19 resulted in an
almost complete block in prApe1p maturation; essentially all of
the Ape1p found in the RAS2val19 strain was in its precursor
form (Fig. 4B). In contrast, 50% of the Ape1p detected in the
wild-type strain was migrating as the mature vacuolar form
(Fig. 4B). The incomplete processing observed in this latter
strain was likely due to the saturation of the Cvt targeting
system brought on by the slightly higher expression provided
by the CUP1 promoter elements (see below). It is important to
point out that the presence of RAS2val19 did not inhibit the
vacuolar delivery and subsequent processing of CPY (Fig. 4C).
CPY is a vacuolar hydrolase that is synthesized as an inactive
zymogen and delivered via the traditional secretory pathway
(73, 79). The processing of both CPY and Ape1p to their mature
forms occurs in the vacuole and is dependent upon proteinase A
2 S. C. Howard and P. K. Herman, unpublished data.
FIG. 3. Elevated levels of Ras/PKA signaling activity blocked
the formation of autophagy pathway intermediates. The pep4
(TVY1) and vam3ts (TDY2) strains carrying either the MET3-RAS2val19
plasmid, pPHY446, or a control vector, pRS413, were grown to mid-log
phase and transferred to nitrogen starvation medium for 3 h. All incu-
bations with the pep4 strains were performed at 30 °C. The vam3ts
strain was grown initially at 26 °C but the incubation in starvation
medium was performed at 37 °C so as to inactivate the thermolabile
Vam3p present. The cells were then collected and processed for electron
microscopy as described under “Experimental Procedures.” The arrows
in the figure indicate the autophagic bodies accumulating in the vacu-
oles of the pep4 strain, and the arrowheads indicate the autophago-
somes present in the cytoplasm of the vam3ts strain. Note that both of
these structures are absent in cells expressing the RAS2val19 allele. The
bar indicates 1 m.
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activity; proteinase A is the product of the PEP4 gene (58, 80,
81). Thus, these data suggest that the vacuole in RAS2val19
cells is competent for prApe1p processing and that the prApe1p
maturation defects observed here were likely due to a block in
the delivery of this precursor to the vacuolar compartment. In
all, these data indicated that, in addition to autophagy, the
Ras/PKA signaling pathway is also negatively regulating the
Cvt targeting pathway in S. cerevisiae.
Previous work has shown that the overexpression of Ape1p
results in the saturation of the Cvt system and in the accumu-
lation of prApe1p in the cytosol (44, 58). However, upon trans-
fer to a starvation medium, this prApe1p is efficiently pro-
cessed to its mature form suggesting that this precursor can be
delivered to the vacuole via the autophagy pathway (44). The
availability of the CUP1-APE1 construct thus provided an ad-
ditional method for evaluating the effect of Ras/PKA signaling
activity on autophagy. For cells containing the CUP1-APE1
construct, the presence of copper in the growth medium re-
sulted in Ape1p levels that were 40-fold higher than those
seen in wild-type cells (data not shown). This level of over-
production saturated the Cvt system and resulted in 95% of
the Ape1p being present in its precursor form in growing cells
(Fig. 5). However, this prApe1p was efficiently processed upon
transfer to the SD-N starvation medium; complete processing
typically required 4 h of incubation at 30 °C (Fig. 5). Consist-
ent with previous work suggesting that this processing was
mediated by the autophagy pathway, we found that the matu-
ration of the overexpressed prApe1p required the activities of
the ATG1 and ATG13 genes (Fig. 5). The presence of the
RAS2val19 allele also resulted in an almost complete block to
this starvation-induced processing of prApe1p (Fig. 5). Thus,
elevated levels of Ras/PKA signaling activity inhibited the vac-
uolar delivery of Ape1p by both the Cvt and autophagy trans-
port pathways.
The Presence of RAS2val19 Did Not Block the Rapamycin-
induced Dephosphorylation of Atg13p—Previous work has
shown that Atg13p is highly phosphorylated in log phase cells
and that most of this phosphate is removed following either
nitrogen starvation or treatment with rapamycin (24, 82). In-
terestingly, the hyperphosphorylated forms of Atg13p migrate
more slowly in SDS-polyacrylamide gels and can be easily
FIG. 4. Elevated levels of Ras/PKA signaling activity inhibited
the expression and processing of the Cvt cargo protein, Ape1p.
A, levels of Ape1p were greatly diminished in RAS2val19 mutants. Pro-
tein extracts were prepared from mid-log phase cultures of the indi-
cated strains. The levels of Ape1p present in these extracts were as-
sessed by a Western immunoblot with a polyclonal antiserum specific
for this protein. The positions of the mature (Ape1p) and precursor
(prApe1p) forms of Ape1p are shown. The relative levels of a cytoplas-
mic protein, Pgk1p, were assessed to ensure that similar amounts of
protein were present in each sample. The strains analyzed were wild-
type (TN125), RAS2val19 (PHY3513), atg1 (YYK126), and atg13
(YYK130). All strains except PHY3513 contained the control vector,
pRS413. The RAS2val19 strain was grown in medium that either lacked
(RAS2val19 (on)) or contained 500 M methionine (RAS2val19 (off)); the
other strains were grown in the medium lacking methionine. B, ele-
vated levels of Ras/PKA signaling activity inhibited the processing of
Ape1p. Strains with the indicated genotypes were transformed with a
plasmid containing the CUP1-APE1 construct. These strains were
grown to mid-log phase in YM-glucose medium and the relative levels of
the two forms of Ape1p were assessed by Western immunoblotting. The
strains analyzed were as in A. C, elevated levels of Ras/PKA signaling
activity did not affect the processing of the vacuolar hydrolase, CPY.
The processing of CPY was assessed as described under “Experimental
Procedures.” Briefly, yeast strains were grown to mid-log phase in
YM-glucose medium and labeled with a [35S]methionine/cysteine mix-
ture for 20 min at 30 °C. An excess of unlabeled amino acids was added,
and this chase incubation was continued at 30 °C for an additional 30
min. Protein extracts were prepared and incubated with an antibody
specific for CPY. The immunoprecipitated proteins were separated on a
7.5% SDS-PAGE gel that was subsequently subjected to autoradiogra-
phy. The positions of the p2 precursor (p2 CPY) and mature (CPY) forms
of CPY are indicated. The strains analyzed were as in A.
FIG. 5. The starvation-induced processing of Ape1p was inhib-
ited by Ras/PKA signaling activity. The CUP1-APE1 construct was
introduced into strains with the indicated genotypes. The strains were
grown to mid-log phase at 30 °C in a YM-glucose medium containing
100 M CuSO4 to induce high level expression from the CUP1 promoter.
The cultures were then transferred to the nitrogen starvation medium,
SD-N, and incubated at 30 °C for 3, 7, or 15 h. Protein extracts were
prepared from these cultures, and the relative levels of Ape1p process-
ing were assessed with a Western immunoblot using a polyclonal anti-
serum specific for Ape1p. The relative processing at each starvation
point (S) was compared with that observed in the mid-log phase, or
nonstarved, control culture (N). The positions of the mature and pre-
cursor forms of Ape1p are shown. The strains analyzed were wild-type
(TN125), RAS2val19 (PHY3513), atg1 (YYK126), and atg13 (YYK130).
All strains except PHY3513 also carried the control vector, pRS413.
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distinguished from the more rapidly migrating, hypophospho-
rylated species found in starved or rapamycin-treated cells (24,
82) (see Fig. 6). Although this phosphorylation of Atg13p is
clearly dependent upon Tor activity, it is not yet known
whether the Tor proteins directly phosphorylate Atg13p or
regulate the activity of a second protein kinase. Therefore, we
tested whether PKA might be responsible for this hyperphos-
phorylation of Atg13p. Specifically, we asked whether the pres-
ence of constitutively elevated levels of Ras/PKA signaling ac-
tivity would prevent the dephosphorylation of Atg13p that
normally occurs upon rapamycin treatment. For this experi-
ment, protein extracts were prepared from wild-type and
RAS2val19 cells that had been treated with rapamycin for 0 or
60 min. The extent of Atg13p phosphorylation was then as-
sessed by examining the relative mobility of this protein on
SDS-polyacrylamide gels. We found that the presence of the
RAS2val19 allele had no significant effect on the mobility of the
Atg13p present in either log phase or rapamycin-treated cells
(Fig. 6). Thus, PKA does not appear to be responsible for the
hyperphosphorylated forms of Atg13p that are observed in log
phase cells.
DISCUSSION
This study examined the effects that the Ras/PKA signaling
pathway had on autophagy in the budding yeast, S. cerevisiae.
All of the work presented here is consistent with the Ras/PKA
pathway having a negative role in the control of this transport
process. For example, elevated levels of Ras/PKA signaling
activity, like those associated with the hyperactive RAS2val19
allele, were found to result in an essentially complete block to
the autophagy process. The autophagy levels present in
RAS2val19 cells were as low as those found in mutants, like
atg1, that were previously characterized as having a nonfunc-
tional autophagy pathway. In addition, the mutational inacti-
vation of the Ras/PKA pathway led to an induction of autoph-
agy activity even in relatively rich growth media that normally
inhibit this transport process. The autophagy levels observed
in these latter studies were comparable to those found in ni-
trogen-starved cells. Thus, the presence of Ras/PKA signaling
activity appears to be both necessary and sufficient for the
inhibition of the autophagy process. Signaling through this
pathway is required to keep the autophagy pathway inactive in
growing cells and an absence of Ras/PKA activity is apparently
necessary for the induction of autophagy that is normally as-
sociated with nutrient deprivation. This type of a regulatory
role would be consistent with a recently proposed model sug-
gesting that the Ras/PKA pathway is a key component of a
growth checkpoint mechanism that functions in S. cerevisiae
cells to ensure that the overall metabolic rate is balanced with
the available nutrient supply (2).
The precise step of the autophagy pathway affected by Ras/
PKA signaling activity is not yet known, but the EM analysis
conducted here suggests that this signaling pathway is target-
ing a relatively early event in this transport process. In partic-
ular, we found that the presence of the RAS2val19 allele blocked
the accumulation of autophagosomes that normally occurs in
the cytosol of vam3 mutants (74). Thus, the Ras/PKA pathway
appears to be regulating an event that is required either before,
or during, the formation of the autophagosome (Fig. 7A). Pos-
sible targets of this regulation would include components of the
pre-autophagosomal structure, the structure that is the site of
autophagosome formation in S. cerevisiae cells (17, 18), or the
membrane source for the sequestering vesicles. Finally, it is
important to point out that these results do not preclude the
possibility that a later step of the autophagy pathway might
also be controlled by this signaling pathway. Further work will
be necessary to identify this early acting target and any other
steps of the autophagy process that might be regulated by
Ras/PKA signaling activity.
Further insight into the role of Ras/PKA signaling activity
was provided by our analysis of Cvt transport. The Cvt path-
way is mechanistically similar to autophagy but generally op-
erates under a different set of nutritional conditions (42, 44,
45). Whereas autophagy is induced by nutrient deprivation,
Cvt transport is responsible for the delivery of proteins to the
FIG. 6. The rapamycin-induced dephosphorylation of Atg13p
was not inhibited by the presence of the RAS2val19 allele. Wild-
type and RAS2val19 cells carrying a high-copy ATG13 plasmid were
grown to mid-log phase and then treated with 0.2 g/ml rapamycin for
0 or 60 min. Protein extracts were prepared and the relative mobility of
Atg13p in an SDS-polyacrylamide gel was assessed by Western immu-
noblotting with a polyclonal antiserum specific for Atg13p. The posi-
tions of the hyperphosphorylated forms of Atg13p found in log phase
cells are indicated (pp-Atg13p). The strains analyzed were wild-type
(TN125 with the control vector, pRS413) and RAS2val19 (PHY3513). The
strains were grown in either medium lacking methionine (wild-type and
RAS2val19 (on)) or containing 500 M methionine (RAS2val19 (off)).
FIG. 7. Potential models to describe how Ras/PKA signaling
activity influences autophagy and how this control might be
coordinated with that of the Tor signaling pathway. A, Ras/PKA
signaling pathway regulates an early event in autophagy, an event that
precedes the formation of the autophagosome. The schematic shows a
number of the steps involved in the autophagy process and the relative
position of the event most likely to be controlled by Ras/PKA signaling
activity. B, schematic depicting the relative order of action of the Ras/
PKA and Tor signaling pathways on the autophagy process. The data
presented here, and in other recent studies, are consistent with the
Ras/PKA pathway acting either (i) independently or (ii) downstream of
the Tor signaling pathway. See the text for further details.
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vacuole in growing cells. Therefore, these transport pathways
could represent two mutually exclusive options and Ras/PKA
activity could have been acting as a switch to promote trans-
port through the Cvt route. However, our data clearly argue
against such a role for this signaling pathway as elevated
Ras/PKA activity also inhibited Cvt transport. Instead, these
observations suggest that the Ras/PKA pathway is regulating a
process that is required during the early stages of both Cvt
transport and autophagy. Finally, it is interesting to note that
elevated levels of Ras/PKA activity not only inhibited Cvt
transport, but also resulted in a decrease in the expression of
the only two known Cvt cargo proteins, Ape1p and Ams1p.
Thus, the Ras/PKA pathway appears to be able to down-regu-
late traffic through the Cvt pathway at multiple levels.
With the data in this report, it is clear that autophagy in
S. cerevisiae is regulated by the activities of both the Ras/PKA
and Tor signaling pathways. An important question that re-
mains concerns the manner in which this control is coordi-
nated. Our data, and that from a recent study, suggest that the
Ras proteins are functioning either (i) independently, or (ii)
downstream of the Tor signaling pathway with respect to au-
tophagy (39) (Fig. 7B). This assertion follows from the obser-
vation that the constitutively activated RAS2val19 allele blocks
the induction of autophagy normally associated with the inac-
tivation of the Tor pathway. These data effectively rule out the
possibility that the Ras proteins are functioning upstream of
the Tor pathway. These same two possibilities have been sug-
gested by studies examining other processes that are controlled
by these signaling pathways (2, 83). In addition, a recent study
of the Rim15p kinase has suggested that the Ras and Tor
pathways function independently to control aspects of Rim15p
function (84). Rim15p is a protein kinase that is required for
the acquisition of stationary phase properties (9, 85). In con-
trast, a second study has suggested that the Ras proteins
function downstream of the Tor signaling pathway (39). This
study examined the effects of these pathways on a variety of
processes known to be controlled by Tor signaling activity,
including protein translation and RNA polymerase I and III
transcription. However, the authors of this latter study ac-
knowledge that their data could also be explained by a model
proposing that the Ras and Tor pathways act independently on
the targets under study (39). Therefore, the precise relation-
ship of these two pathways to one another is not yet clear. A
definitive order could be imposed if we had a constitutively
active allele of one of the TOR genes; this allele would be
essentially the TOR equivalent of the RAS2val19 allele. This
type of an allele would allow us to test whether the activation
of the Tor pathway would be able to suppress phenotypes
associated with a loss of Ras/PKA signaling activity. In lieu of
such a reagent, additional work would appear to be required
before we can definitely assign a relative order to these signal-
ing pathways.
In summary, the data presented here suggest that the Ras/
PKA pathway regulates an early step of both the autophagy
and Cvt transport processes. Clearly, one of the main priorities
of our future work will be the identification of the PKA sub-
strate that is responsible for the regulatory effects observed in
this study.
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